Used in research as a potential anticancer agent, particularly studied for its activity against various tumor cell lines. It functions as a tubulin polymerization inhibitor, disrupting microtubule formation in cells, which leads to cell cycle arrest and apoptosis. Shows strong cytotoxic effects in breast, colon, and prostate cancer models. Also investigated for its anti-angiogenic properties, meaning it may help prevent the formation of new blood vessels that support tumor growth. Due to its stilbene and trimethoxyphenyl motifs, it is considered a synthetic analog of combretastatin A-4, aiming to improve stability and efficacy. Primarily used in preclinical studies to develop novel chemotherapeutic agents.